| Literature DB >> 31003079 |
Rosália Maria Tôrres de Lima1, Antonielly Campinho Dos Reis2, José Victor de Oliveira Santos2, José Roberto de Oliveira Ferreira3, Antonio Lima Braga2, José Williams Gomes de Oliveira Filho1, Ag-Anne Pereira Melo de Menezes2, Ana Maria Oliveira Ferreira da Mata1, Marcus Vinícius Oliveira Barros de Alencar2, Debora Caroline do Nascimento Rodrigues4, Paulo Michel Pinheiro Ferreira5, Teresinha de Jesus Aguiar Dos Santos Andrade6, Juan Carlos Ramos Gonçalves7, Felipe Cavalcanti Carneiro da Silva8, João Marcelo de Castro E Sousa9, Ana Amélia de Carvalho Melo Cavalcante10.
Abstract
Gingerol - [6]-gingerol ((S)-5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-3-decanone; [6]-G) - is a phenolic compound with several pharmacological properties. Herein, the aim of the study was to evaluate the toxicogenic effects of [6]-G on Artemia salina nauplii, Allium cepa, HL-60 cell line and Sarcoma 180 (S-180) ascitic fluid cells.For toxic and genotoxic analysis, it was used [6]-G concentrations of 5, 10, 20 and 40 μg mL-1. For cytotoxic evaluation using the MTT test (3- [4,5-dimethyl-thiazol-2-yl] -2,5-diphenyl tetrazolium bromide), serial [6]-G dilutions (1.56-100 μg mL-1) were performed, and S-180, HL-60 and peripheral blood mononuclear cells (PBMC) were treated for 72 h. The IC50 of [6]-G were 1.14, 5.73 and 11.18 μg mL-1 for HL-60, S-180 and PBMC, respectively, indicating a possible selectivity against tumor cell lines. At higher concentrations (>10 μg mL-1), toxicity and genotoxicity were observed in the A. cepa test, especially at 40 μg mL-1. Mechanisms indicating apoptosis, such as toxicity, cytotoxicity and nuclear abnormalities (bridges, fragments, delays, loose chromosomes and micronuclei) suggest that [6]-G has potential for antitumor pharmaceutical formulations.Entities:
Keywords: Antitumor activity; Toxicogenic; [6]-Gingerol
Year: 2019 PMID: 31003079 DOI: 10.1016/j.biopha.2019.108873
Source DB: PubMed Journal: Biomed Pharmacother ISSN: 0753-3322 Impact factor: 6.529